Sign in

CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company

Ernexa Therapeutics Inc.

Sign in to watch
Ticker
ERNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
311103425
Phone
(617) 798-6700
Business address
1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
Former names
Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC

Securities

  • ERNA Common Stock Nasdaq
  • ERNAW Warrants Nasdaq
  1. 8-K Event Material agreement · Executive or director change
  2. 3 Insider Initial Statement of Ownership
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. UPLOAD Other SEC-generated Letter
  6. UPLOAD Other SEC-generated Letter
  7. 8-K Event Results of operations
  8. 10-Q Report Quarterly Report
  9. SC 13D/A Stake Beneficial Ownership Report
  10. 4 Insider Changes in Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 8-K Event Material agreement
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 5 Insider Annual Insider Trading Report
  19. 8-K Event Executive or director change
  20. 8-K Event Executive or director change

Page 65 of 77 · 1,525 filings